Key points from article :
Longevica created a biotechnology platform for longevity after researching the life-span of laboratory mice.
Spent 11 years researching supplements to increase human longevity.
Attracted a total of $13 million from investors, including Alexander Chikunov, a longevity investor.
It now aims to produce medicines, dietary supplements and food products.
"By 2026, the sales of services and products for this audience will be around $27 trillion," - Aynar Abdrakhmanov, CEO at Longevica.
"Large-scale screening of all known pharmacological substances on long-lived mice to find those that prolong life," - Chikunov.
Five substances significantly increased longevity by 16-22%: Inulin, Pentetic Acid, Clofibrate, Proscillaridin A, D-Valine.
Formed a view about the elimination of certain heavy metals from the body and improved the body’s ability to remove toxins.
